/

/

MindBio Therapeutics Receives Approval for First-Ever Phase 2 Trial of LSD Microdosing

Wed, May 24

Perspectives

MindBio has received regulatory approval for the world’s first take-home Phase 2 trial of LSD-microdosing for depression. This is a major step in advancing clinical data for microdosing. @MindBioTherap $MBIO https://t.co/v2M2zsUtU5

10964

MindBio Therapeutics Ethics Approval for Landmark World First Phase 2 Clinical Trial of Take-Home LSD-Microdosing for Major Depressive Disorder

Discover